HomeMarket NewsApogee Therapeutics Triumphs with Encouraging Q4 2023 Earnings Results

Apogee Therapeutics Triumphs with Encouraging Q4 2023 Earnings Results

Actionable Trade Ideas

always free

APGE stock - APGE Stock Earnings: Apogee Therapeutics Beats EPS for Q4 2023

Source: iQoncept / Shutterstock

Apogee Therapeutics (NASDAQ:APGE) recently unveiled its performance for the final quarter of 2023.

  • Remarkably, Apogee Therapeutics posted earnings per share of -32 cents, surpassing analysts’ projections of -49 cents for EPS.
  • However, the company did not disclose any revenue figures for the quarter.

At InvestorPlace, we utilize TradeSmith’s data to automate our coverage of quarterly earnings releases. This innovative approach allows us to promptly share crucial details such as earnings per share and revenue, in addition to how a firm fares against analyst forecasts. Our aim is to keep our readers updated with the most recent financial numbers without delay. Should you spot any concerns or inaccuracies, please reach out to us at [email protected].


Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/apge-stock-earnings-apogee-therapeutics-for-q4-of-2023/.

©2024 InvestorPlace Media, LLC

Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.